The aims of the current study were to 1) compare the serum CEA levels at time of primary and recurrent CRC diagnosis and 2) determine serum CEA levels in rectal cancers at primary diagnosis, as per Grossmann et al [10], and to identify potential factors influencing differing CEA levels. Here, CEACAM5 is linked to colorectal carcinoma.